LiveRamp Holdings, Inc. (RAMP): what the price assumes

In the published model solve dated 2026-Q2, anchored at $37.75, LiveRamp Holdings, Inc. (RAMP) is priced for today's economics sustained for ~6.0 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/RAMP

Headline

FieldValue
TickerRAMP
CompanyLiveRamp Holdings, Inc.
Current price$37.75/sh
CompositionSubscription 76% / Marketplace and Other 24%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)3.9%
Operating margin today10.3%
Margin compression (value-band)-6.4pp
Must persist for6.0y
Multiple paid23x operating income

The operating-margin figure is value-band context at year 9: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 10.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~1.7 years.

Reconcile: at the x-ray's 9.3% required return this reads ~20.8%/yr; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history+0.10σ
cohort percentile (of 187 peers)37
sustained it ~6 years at this level28%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.32x5expensive
Earnings1.56x3expensive
Relative0.66x5justifies
Growth1.17x3expensive

Families that justify the price: Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$21.881.73xyesFCF base $0.0B, growth 9% (input: historical growth), terminal g 4.0%, WACC 9.2%, 6yr projection
DCF Exit MultipleGrowth$36.511.03xyesExit EV/EBITDA: 20.1x / 22.1x / 24.1x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$57.050.66xyesP/E 27.22x (blended: static sector reference 35x + trailing (TTM) 16x), scenarios: 22.6x / 27.2x / 31.9x (bear / base = reference held flat / bull), EV/EBITDA 25x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$26.261.44xyesBV/sh $16.18, ROE (TTM) 15.0%, ke 9.3%
Two-Stage Excess ReturnAsset$33.061.14xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$32.391.17xyesRev $0.8B, growth 9% (input: historical growth; tapered), Terminal P/S: 2.3x / 2.8x / 3.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$26.881.40xyesEPS $2.24, growth 2% (input: historical EPS growth), PEG=7.77 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$33.911.11xyesBV $16.18 + 5yr PV of (ROE (TTM) 15.0% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$28.551.32xyes√(22.5 × EPS $2.24 × BVPS $16.18) — Graham's conservative floor
EV/EBITDA RelativeRelative$41.960.90xyesEBITDA $0.09B × sector EV/EBITDA 25.0x
FCF YieldEarnings$13.062.89xyesFCF $40.2M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$72.280.52xyesEPS $2.24 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$3.4211.04xyesBV $16.18 × (ROIC 1.9% / WACC 9.2%)
P/Sales SectorRelative$108.230.35xyesRevenue $0.81B × sector P/S 8.0x
PEG Fair ValueRelative$84.000.45xyesEPS $2.24 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$24.221.56xyesEPS $2.24 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$387.0m
Net debt / NOPAT (after-tax)-5.87x (net cash)
Net debt / operating income (pre-tax)-4.64x (net cash)
Share count CAGR (buyback)-1.5%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

The dominant fact overrides the model: LiveRamp has agreed to be acquired by Publicis Groupe in an all-cash transaction with an equity value of about $2.5 billion. At $37.73 the stock now trades against deal terms and closing odds, not standalone fundamentals.

The standalone business underneath is solid. Fiscal 2026 revenue was $813 million, up 9%, annual recurring revenue reached $545 million, subscription net retention was 107%, and the company generated record operating cash flow of $168 million with a net cash balance near $387 million and no debt.

With a pending all-cash deal, the standard valuation methods are secondary. The reasonable-value band centered near $33 reflected the standalone economics; the cash price an acquirer agreed to pay is the number that now anchors the stock, and the residual question is deal completion, not intrinsic growth.

Bull Case

Read through the lens of capital allocation and the LiveRamp story resolves into its conclusion: management built a cash-generative, debt-free business and is now monetizing it through a sale. The company has agreed to be acquired by Publicis Groupe in an all-cash transaction valuing the equity at roughly $2.5 billion. For a holder, the bull case is straightforward, the value is being crystallized in cash rather than left to the market's mood, and an all-cash deal removes the execution and re-rating risk that a standalone software company carries.

The capital-allocation record that led here is the supporting evidence. LiveRamp entered the deal carrying net cash near $387 million and no debt, having generated record annual operating cash flow of $168 million in fiscal 2026 and repurchased about 7.1 million shares for $194 million during the year. A company that returns cash aggressively while building a clean balance sheet is one that an acquirer can buy without untangling leverage, and the buyback shrank the share count into the deal.

The asset being sold is a genuine network. LiveRamp describes data collaboration "using clean room technology" that "enables data collaboration between organizations and their trusted partners in a neutral, manageable environment" (FY2025 10-K, accession 0000733269-25-000030). For Publicis, an advertising holding company, owning the neutral identity-and-collaboration layer that connects marketers to their data is strategically valuable, which is why a strategic buyer was willing to pay cash. Fiscal 2026 revenue grew 9% to $813 million with subscription net retention at 107%, so the business was sold while still growing, not in distress. The bull case is that the deal closes near its agreed terms and the cash arrives.

Bear Case

The moat-erosion thesis is what makes the sale itself the most telling signal. LiveRamp's advantage rested on being the neutral identity and data-collaboration layer for digital advertising, but that neutrality is exactly what is under pressure as the ecosystem reorganizes around walled gardens and retail media networks that prefer to own their own clean rooms. The company's own filing notes its data-marketplace and usage-based revenue "fluctuate based on seasonal factors that affect the advertising" market (FY2025 10-K, accession 0000733269-25-000030), a reminder that the demand is tied to ad budgets the company does not control. A standalone identity intermediary faces a structural question about whether the largest platforms route around it, and selling to an advertising holding company can be read as choosing a strategic home before that erosion forces the issue.

For a current holder, though, the bear case is no longer about the long-run moat; it is about the deal. With an all-cash agreement at roughly $2.5 billion in place, the risk has shifted from business fundamentals to completion risk: regulatory review, the chance the transaction is delayed, repriced, or blocked, and the limited upside if it closes as agreed. The stock at $37.73 (June 28, 2026) already reflects most of the announced value, so the asymmetry is unattractive, modest gain if it closes on schedule, meaningful downside if it breaks and the stock falls back to standalone value.

That standalone value is below where a broken deal would need to land for comfort. The methods that price the business on its own footing cluster in the mid-$20s to mid-$30s: the perpetual-growth DCF near $20, simple excess return near $25, residual income near $32, and the reasonable-value base near $33. The blended central estimate is about $29. If the Publicis deal were to fall through, the price would re-rate toward those standalone levels, below the current quote. The bear case is simply that a holder is now underwriting deal completion for limited reward, with standalone value as the downside.

Valuation

The valuation framework changes character once a definitive all-cash acquisition is on the table. LiveRamp has agreed to be acquired by Publicis Groupe at an equity value of roughly $2.5 billion in cash, so the price is now governed by the deal terms and the probability and timing of closing, not by the intrinsic-value methods. The standard model output is best read as the standalone floor the stock would revert to if the deal failed.

On that standalone basis, the inversion read the price as a long-duration growth bet: about 23 times company-wide operating income, implying the company holds an elevated growth pace for roughly six years, which the model flagged as elevated. The method families split as a moderate-growth software name should: the relative family sits above the price (sector P/E value near $54, EV/EBITDA near $39), while the growth and asset families cluster lower (perpetual-growth DCF near $20, simple excess return near $25, residual income near $32, two-stage excess return near $31). The blended central estimate is about $29, and the reasonable-growth band runs from about $24 at the low to $33 at the base, with the high case near $39.

The balance sheet is pristine (net cash near $387 million, no debt, record operating cash flow of $168 million), which is part of why a strategic buyer found the asset attractive. For valuation purposes the operative number is the cash deal price and the discount the market applies for completion risk, with the mid-$20s-to-low-$30s standalone range as the downside reference if the transaction does not close.

Catalysts

The overriding catalyst is the announced acquisition: LiveRamp has agreed to be acquired by Publicis Groupe in an all-cash transaction valuing the equity at roughly $2.5 billion. Every other consideration is now secondary to this deal. The key milestones to watch are regulatory review, any shareholder vote, and the expected closing timeline, since the stock's path is governed by completion odds rather than operating results.

The last standalone results, fiscal 2026 reported in May 2026, showed the business in good health: revenue of $813 million (up 9%), annual recurring revenue of $545 million (up 8%), subscription net retention of 107%, and record operating cash flow of $168 million, with about 7.1 million shares repurchased for $194 million during the year. Those figures matter mainly as the downside reference if the deal were to break.

The principal risk is deal completion risk: a regulatory challenge, a delay, or a collapse of the transaction would send the stock back toward standalone value in the high-$20s to low-$30s. For a holder, monitoring the regulatory and closing process is the entire near-term job.

Sources: LiveRamp fiscal 2026 results and Publicis acquisition announcement (GlobeNewswire, Yahoo Finance, QuiverQuant, LiveRamp investor relations).

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive RAMP report on boothcheck